NCT02816853View on ClinicalTrials.gov

Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Chinese Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Healthy
Interventions
DRUG

Domperidone

Domperidone 10 mg or 20 mg tablets will be administered.

DRUG

Placebo

Matching placebo will be administered.

DRUG

Moxifloxacin

Moxifloxacin 400 mg tablet will be administered.

Trial Locations (1)

Unknown

Beijing

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT02816853 - Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Chinese Healthy Participants | Biotech Hunter | Biotech Hunter